Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangniaosuan is a traditional Chinese herbal medicine formula commonly used in China for the treatment of hyperuricemia. It is typically administered as granules or decoctions and may be referred to as "Jiangniaosuan formula" (JNSF) or "Songge Jiangniaosuan Granules." The precise composition includes multiple herbs, but detailed ingredient lists are not specified in the available sources. The mechanism of action is presumed to involve lowering serum uric acid levels and improving symptoms associated with hyperuricemia, potentially through modulation of metabolic pathways and anti-inflammatory effects. Clinical studies have been conducted to evaluate its efficacy for hyperuricemia[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiangniaosuan.